Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors
Salivary gland tumors (SGTs) comprise a group of rare neoplasms. Locally aggressive, recurrent and/or metastatic SGTs are notorious for their resistance to systemic therapy, making the need for carefully designed, prospective and randomized trials with useful predictive markers mandatory to define n...
Main Authors: | Despoina Pouloudi, Maria Manou, Panagiotis Sarantis, Nikolaos Tsoukalas, Gerasimos Tsourouflis, Eougken Dana, Michalis V. Karamouzis, Jerzy Klijanienko, Stamatios Theocharis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/3/517 |
Similar Items
-
The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors
by: Despoina Pouloudi, et al.
Published: (2020-12-01) -
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
by: Giorgio Milazzo, et al.
Published: (2020-05-01) -
Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
by: Wang Y, et al.
Published: (2017-05-01) -
Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
by: Dimitrios Goutas, et al.
Published: (2021-07-01) -
Synthesis of Sulfonamides and Evaluation of Their Histone Deacetylase (HDAC) Activity
by: Jae–Chul Jung, et al.
Published: (2007-05-01)